Pediatrics

Latest News

Real-World Evidence Shows 82% Reduction in Infant RSV Hospitalizations With Nirsevimab
Real-World Evidence Shows 82% Reduction in Infant RSV Hospitalizations With Nirsevimab

May 3rd 2024

The results reinforce other real-world evidence from several broad infant immunization programs in the US, Spain, and France.

FDA Accepts Supplemental New Drug Application for Tapinarof Cream, 1%, in Atopic Dermatitis
FDA Accepts Supplemental New Drug Application for Tapinarof Cream, 1%, in Atopic Dermatitis

April 29th 2024

cannabis background | Image Credit: yellowj - stock.adobe.com
Recreational Cannabis Legalization Associated with Decreases in Alcohol, E-Cigarette Use

April 29th 2024

FDA approval seal -- Image credit: Aquir | stock.adobe.com
FDA Approves Mavorixafor Capsules to Treat Patients With WHIM Syndrome

April 29th 2024

FDA approval stamp -- Image credit: Olivier Le Moal | stock.adobe.com
FDA Approves Lutathera for Pediatric Patients With SSTR+ Gastroenteropancreatic Neuroendocrine Tumors

April 23rd 2024

More News

© 2024 MJH Life Sciences

All rights reserved.